Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04765020
Status:
RECRUITING
Last Update Posted:
2022-11-03
First Post:
2021-01-26
Brief Title:
Cardiorespiratory Fitness in Children and Adolescents After Cancer Treatment
Sponsor:
Universität Duisburg-Essen
Organization:
Universität Duisburg-Essen
Study Overview
Official Title:
Effects of a Physical Activity Program On Cardiorespiratory Fitness in Children and Adolescents folloWing Acute cancER Treatment a Randomized Controlled Trial
Status:
RECRUITING
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
POWER
Brief Summary:
The POWER-study is a two-arm exercise intervention study for pediatric patients following acute cancer treatment This clinical trial will investigate the effects of a 12-week moderate to high-intensity exercise program on cardiorespiratory fitness in children and adolescents beginning 6 weeks after completion of acute cancer treatment
Detailed Description:
The main objective of the POWER study is to investigate the effects of a 12-week moderate to high-intensity partially supervised exercise program on cardiorespiratory fitness VO2peak in children and adolescents who have completed acute cancer treatment This randomized controlled trial will include n56 patients Patients will be randomly assigned to the intervention or the control group Patients in the intervention group will perform two supervised exercise sessions per week one personal training session and one group-based training session During an initial consultation both groups receive recommendations for individual physical activity goals and a brochure with exercise recommendations as well as a fitness tracker to monitor their daily physical activity Only the intervention group will receive daily activity targets which will be adjusted on a regular basis The study starts 6 weeks after completion of the patients acute cancer treatment
Secondary aims of this interventional study are to evaluate additional performance markers including muscle strength functional mobility balance body composition and patient-reported outcomes including QoL fatigue and cognitive function as well as blood markers to evaluate changes in metabolic immune and heart health
Secondary aims of this interventional study are to evaluate additional performance markers including muscle strength functional mobility balance body composition and patient-reported outcomes including QoL fatigue and cognitive function as well as blood markers to evaluate changes in metabolic immune and heart health
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None